Research ArticleClinical Investigation
Open Access
Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with 131I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
Alberto Signore, Giuseppe Campagna, Jessica Marinaccio, Marco de Vitis, Chiara Lauri, Francesco Berardinelli, Anna Tofani, Marco Chianelli, Marina Borro, Giovanna Gentile, Maurizio Simmaco, Francesco Colombini, Anna Giovanetti and Antonella Sgura
Journal of Nuclear Medicine October 2022, 63 (10) 1515-1522; DOI: https://doi.org/10.2967/jnumed.121.263442
Alberto Signore
1Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, University of Rome “Sapienza,” Rome, Italy;
Giuseppe Campagna
1Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, University of Rome “Sapienza,” Rome, Italy;
Jessica Marinaccio
2Department of Science, University of Rome “Roma Tre,” Rome, Italy;
Marco de Vitis
2Department of Science, University of Rome “Roma Tre,” Rome, Italy;
Chiara Lauri
1Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, University of Rome “Sapienza,” Rome, Italy;
Francesco Berardinelli
2Department of Science, University of Rome “Roma Tre,” Rome, Italy;
Anna Tofani
1Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, University of Rome “Sapienza,” Rome, Italy;
Marco Chianelli
3Unit of Endocrinology, Regina Apostolorum Hospital, Rome, Italy;
Marina Borro
4Department of Neurosciences, Mental Health, and Sensory Organs, Faculty of Medicine and Psychology, University of Rome “Sapienza,” Rome, Italy;
Giovanna Gentile
4Department of Neurosciences, Mental Health, and Sensory Organs, Faculty of Medicine and Psychology, University of Rome “Sapienza,” Rome, Italy;
Maurizio Simmaco
4Department of Neurosciences, Mental Health, and Sensory Organs, Faculty of Medicine and Psychology, University of Rome “Sapienza,” Rome, Italy;
Francesco Colombini
5Diacron International SRL, Grosseto, Italy; and
Anna Giovanetti
6ENEA, Division of Health Protection Technologies, Casaccia Research Centre, Rome, Italy
Antonella Sgura
2Department of Science, University of Rome “Roma Tre,” Rome, Italy;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 10
October 1, 2022
Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with 131I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
Alberto Signore, Giuseppe Campagna, Jessica Marinaccio, Marco de Vitis, Chiara Lauri, Francesco Berardinelli, Anna Tofani, Marco Chianelli, Marina Borro, Giovanna Gentile, Maurizio Simmaco, Francesco Colombini, Anna Giovanetti, Antonella Sgura
Journal of Nuclear Medicine Oct 2022, 63 (10) 1515-1522; DOI: 10.2967/jnumed.121.263442
Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with 131I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
Alberto Signore, Giuseppe Campagna, Jessica Marinaccio, Marco de Vitis, Chiara Lauri, Francesco Berardinelli, Anna Tofani, Marco Chianelli, Marina Borro, Giovanna Gentile, Maurizio Simmaco, Francesco Colombini, Anna Giovanetti, Antonella Sgura
Journal of Nuclear Medicine Oct 2022, 63 (10) 1515-1522; DOI: 10.2967/jnumed.121.263442
Jump to section
Related Articles
Cited By...
- No citing articles found.